Spots Global Cancer Trial Database for A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
Official Title: A Phase III Confirmatory Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia
Study ID: NCT05440383
Study Description
Brief Summary: Multi-center, randomized, double-blind, parallel-group study to confirm non-inferiority of KLH-2109 to Leuprorelin acetate in uterine fibroids patient with menorrhagia
Detailed Description:
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Clinical Resarch Site, Multiple Locations, , Japan
Contact Details
Name: Yoshitaka Shimizu
Affiliation: Kissei Pharmaceutical Co., Ltd.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
